Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects

被引:8
|
作者
Jin, Ni [1 ,2 ,3 ]
Sha, Weiwei [2 ,3 ]
Gao, Lixiong [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 3, Dept Ophthalmol, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Dept Endocrinol, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China
关键词
microglia; stem cell therapy; retinal degenerative disease; microglial polarization; retinal inflammation; MACULAR DEGENERATION; IN-VITRO; PIGMENT EPITHELIUM; DIRECTED DIFFERENTIATION; EXTRACELLULAR VESICLES; NEUROTROPHIC FACTORS; ACTIVATED MICROGLIA; GANGLION-CELLS; MOUSE MODEL; EXPRESSION;
D O I
10.3389/fcell.2021.741368
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Retinal degenerative disease (RDD) refers to a group of diseases with retinal degeneration that cause vision loss and affect people's daily lives. Various therapies have been proposed, among which stem cell therapy (SCT) holds great promise for the treatment of RDDs. Microglia are immune cells in the retina that have two activation phenotypes, namely, pro-inflammatory M1 and anti-inflammatory M2 phenotypes. These cells play an important role in the pathological progression of RDDs, especially in terms of retinal inflammation. Recent studies have extensively investigated the therapeutic potential of stem cell therapy in treating RDDs, including the immunomodulatory effects targeting microglia. In this review, we substantially summarized the characteristics of RDDs and microglia, discussed the microglial changes and phenotypic transformation of M1 microglia to M2 microglia after SCT, and proposed future directions for SCT in treating RDDs.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
    Holan, Vladimir
    Palacka, Katerina
    Hermankova, Barbora
    CELLS, 2021, 10 (03) : 1 - 21
  • [22] Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases
    Boia, R.
    Madeira, M. H.
    Aires, I. D.
    Neves, C. R.
    Ambrosio, A. F.
    Santiago, A. R.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [23] Contribution of Microglia-Mediated Neuroinflammation to Retinal Degenerative Diseases
    Madeira, Maria H.
    Boia, Raquel
    Santos, Paulo F.
    Ambrosio, Antonio F.
    Santiago, Ana R.
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [24] Prospects of Stem Cells for Retinal Diseases
    Ng, Tsz Kin
    Lam, Dennis S. C.
    Cheung, Herman S.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2013, 2 (01): : 57 - 63
  • [25] Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?
    Alcalde, Ignacio
    Sanchez-Fernandez, Cristina
    Martin, Carla
    De Pablo, Nagore
    Jemni-Damer, Nahla
    Guinea, Gustavo V.
    Merayo-Lloves, Jesus
    Del Olmo-Aguado, Susana
    MEDICINA-LITHUANIA, 2022, 58 (01):
  • [26] Stem cell therapy in retinal diseases: current evidence
    Rubinato, Leopoldo
    de Zan, Enrico Redolfi
    Sarao, Valentina
    Veritti, Daniele
    Lanzetta, Paolo
    EXPERT REVIEW OF OPHTHALMOLOGY, 2024, 19 (02) : 119 - 131
  • [27] Epigenetics and Degenerative Retinal Diseases: Prospects for New Therapeutic Approaches
    Barnstable, Colin J.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2022, 11 (04): : 328 - 334
  • [28] Adult stem cell-based therapy for degenerative joint diseases
    Alexander, Peter G.
    Tuan, Rocky S.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [29] Adult stem cell-based therapy for degenerative joint diseases
    Peter G Alexander
    Rocky S Tuan
    Arthritis Research & Therapy, 14 (Suppl 1):
  • [30] Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future
    Luo, Mingyue
    Chen, Youxin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (01) : 150 - 159